Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07490132

Endoscopic Retrograde Cholangiopancreatography

The risk of post-endoscopic retrograde cholangiopancreatography(ERCP) pancreatitis(PEP) is influenced by patient and procedure-related factors. Strategies to decrease PEP(Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis) are of great importance.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Gastro-Intestinal Disorder Digestive System Diseases

Age range

15 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

About this study

The primary objective of this study is to provide a mechanism to store the following information about patients undergoing ERCPs at Methodist Dallas Medical Center. This registry will be permissive of quality improvement and research studies.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients >15 years Included in MDI's Registry Underwent ERCP between January 1, 2000 through December 31, 2025

Exclusion criteria

Patients <15 years Patients in which cannulation was via a surgical anastomosis Patients in which cannulation was not attempted due to gastric outlet obstruction, the main papilla not found, or the minor papilla was not found will be excluded.

Treatment and study plan

Patients undergoing ERCPs at Methodist Dallas Medical Center

Other

The registry will include all patients who meet registry inclusion. Enrollment will terminate once 25 years of data are captured: January 1, 2000 through December 31, 2025.

Primary outcomes

  1. Underwent ERCP

    Time frame: 25 years

    Patients undergoing ERCPs at Methodist Dallas Medical Center.

Study contacts

Contact information is provided by the study sponsor or research team.

Crystee Cooper, DHEd

CONTACT

[email protected]

214-947-1280

Kavya Mankulangara

CONTACT

[email protected]

214-947-4604

Sponsors and collaborators

Lead sponsor

Methodist Health System

Other

Registry information

Official study title

Endoscopic Retrograde Cholangiopancreatography Patient Registry

Important dates

Study start
2026
Primary completion
2027
Study completion
2028
First posted
Mar 24, 2026
Registry last updated
Mar 24, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.